Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/30/6a/6a/306a6a27-5590-6622-dfba-7d6a7d0dbbb0/mza_1420088730083196311.jpg/600x600bb.jpg
CannMed Coffee Talk
Medicinal Genomics
133 episodes
2 weeks ago
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
RSS
All content for CannMed Coffee Talk is the property of Medicinal Genomics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
https://cannmedevents.com/wp-content/uploads/2025/02/Coffee-Talk-Podcast-STACI25Artboard-1.jpg
Examining Long-Term Effects of Medical Cannabis with Staci Gruber, PhD
CannMed Coffee Talk
46 minutes 34 seconds
9 months ago
Examining Long-Term Effects of Medical Cannabis with Staci Gruber, PhD
Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School.



Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND) in 2014, the first ever program of its kind designed to clarify the long-term impact of medical cannabis use. MIND supports numerous projects that aim to address the impact of medical cannabis on a number of important variables including cognition, brain structure and function, clinical state, quality of life, pain, sleep, and other health-related measures. As director of MIND, Dr. Gruber has generated major contributions to the field as the first to assess medical cannabis patients longitudinally, first to acquire neuroimaging data in medical cannabis patients, and as Principal Investigator of the first clinical trial of a full-spectrum, high-cannabidiol (CBD) product, which she specifically formulated to treat anxiety. Additional, novel clinical trials have been approved and are pending or currently underway.



At CannMed 25 Staci will share findings from those clinical trials as an oral presenter. https://cannmedevents.com/staci-gruber-phd/



Topics Discussed:




Key findings from the MIND Program’s longitudinal studies on medical cannabis use (improved cognitive performance and reductions in pain, anxiety, and sleep disturbances)



Ongoing clinical trials the MIND Program is conducting on anxiety, bipolar disorder, and Alzheimer’s



The Women’s Health Initiative at MIND (WHIM) investigating cannabis for gynecologic pain, menopause, and endometriosis



Concerns about mislabeled cannabis products and unregulated hemp-derived products



and more!




Thanks to This Episode's Sponsor: Healer



Healer is a trusted, physician-developed medicinal cannabis brand founded to address the challenges of helping people and health providers get the best results with safe, reliably dosable products and education on how to best use them. Healer Hemp products are available nationwide and include a step-by-step usage guide and response tracker. Healer’s distinctive product formulations and education are based on the latest research and work of leading cannabis clinician, Dr. Dustin Sulak, D.O.



Visit Healer.com or HealerCbd.com



Additional Resources




https://www.drstacigruber.com



Social Media: @DrStaciGruber on X and Instagram



Register for CannMed 25



Meet the CannMed 25 Speakers



Review the Podcast



CannMed Archive
CannMed Coffee Talk
Brought to you by Medicinal Genomics & Advanced Nutrients